Stock PANACEABIO PANACEA BIOTEC LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Panacea Biotec Limited Bombay S.E.

Equities

PANACEABIO

INE922B01023

Market Closed - Bombay S.E.
Other stock markets
 03:30:52 26/06/2024 pm IST 		5-day change 1st Jan Change
138.7 INR +1.09% Intraday chart for Panacea Biotec Limited +4.92% -17.47%
24/06 Panacea Biotec Unit Forms New Wholly-Owned Subsidiary in US MT
31/05 Panacea Biotec Limited and Panacea Biotec Pharma Limited Approves Re-Designation of Ankesh Jain to Whole-Time Director, Effective June 01, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Panacea Biotec Unit Forms New Wholly-Owned Subsidiary in US
MT
Panacea Biotec Limited and Panacea Biotec Pharma Limited Approves Re-Designation of Ankesh Jain to Whole-Time Director, Effective June 01, 2024
CI
Panacea Biotec Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Panacea Biotec Limited Appoints Ambika Sharma as Non-Executive Independent Director
CI
Panacea Biotec Limited Announces the Cessation of Mr. Krishna Murari Lal, Mr. Namdeo Narayan Khamitkar and Mr. Raghava Lakshmi Narasimhan as Independent Directors
CI
Panacea Biotec Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Panacea Biotec Launches EasyFourPol® in India and Receives Registration of Valganciclovir Powder for Oral Solution in Germany
CI
Panacea Biotec Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Panacea Biotec Launches Generic Cancer Treatment Drug in Canada
MT
Panacea Biotec's Arm Gets Nine Observations from US FDA
MT
Indian Immunologicals targets dengue vaccine launch by Jan 2026
RE
Panacea Biotec Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Panacea Biotec Launches New Pediatric Food, Nutritional Products
MT
Panacea Biotec Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Panacea Biotec Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
CI
Panacea Biotec : Audited Financial Results for quarter and financial year ended March 31, 2023
PU
Panacea Biotec Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Panacea Biotec Limited Reports Earnings Results for the Nine Months Ended December 31, 2022
CI
Panacea Biotec Donates Pentavalent Vaccine to Cuba
MT
Panacea Biotec Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PANACEABIO Stock
  4. PANACEABIO Stock
  5. News Panacea Biotec Limited